EPO and Alzheimer disease: This study tested the hypothesis that a 21-day normobaric IHT regimen improves learning-memory behavior, diminishes Aβ40 and Aβ42 accumulation in cerebral cortex and hippocampus, and enhances cerebrocortical EPO and BDNF contents in transgenic AD mice.